BRIDGEWAY CAPITAL MANAGEMENT, LLC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 37 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$84,030
+32.8%
120,300
+71.1%
0.00%0.0%
Q4 2022$63,270
-90.9%
70,300
-39.0%
0.00%
-89.5%
Q3 2022$692,000
+31.3%
115,300
-9.4%
0.02%
+58.3%
Q2 2022$527,000
+18.2%
127,300
+8.5%
0.01%
+33.3%
Q1 2022$446,000
-5.9%
117,300
+11.4%
0.01%0.0%
Q4 2021$474,000
-24.8%
105,300
-22.2%
0.01%
-25.0%
Q3 2021$630,000
+258.0%
135,300
+441.2%
0.01%
+300.0%
Q2 2021$176,000
+18.9%
25,0000.0%0.00%0.0%
Q1 2021$148,000
+28.7%
25,0000.0%0.00%
+50.0%
Q4 2020$115,00025,0000.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,118,761$14,533,0003.83%
Ghost Tree Capital, LLC 904,225$4,214,0001.23%
RA Capital Management 5,914,252$27,560,0000.38%
Vivo Capital, LLC 1,232,394$5,743,0000.26%
Nan Fung Group Holdings Ltd 142,900$666,0000.21%
Ikarian Capital, LLC 629,384$2,934,0000.21%
NEA Management Company, LLC 3,142,958$14,646,0000.17%
SAMLYN CAPITAL, LLC 1,716,067$7,998,0000.11%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,788,0000.09%
GSA CAPITAL PARTNERS LLP 90,665$422,0000.04%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders